Mankind Pharma Limited (NSE: MANKIND)

Market Cap	1.17T
Revenue (ttm)	110.18B
Net Income (ttm)	21.15B
Shares Out	400.66M
EPS (ttm)	52.70
PE Ratio	55.23
Forward PE	51.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,151,114
Open	2,974.90
Previous Close	2,998.40
Day's Range	2,846.05 - 2,974.90
52-Week Range	1,901.05 - 3,054.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 4, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 19,540
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANKIND

Financial Performance

In 2023, Mankind Pharma's revenue was 103.35 billion, an increase of 18.12% compared to the previous year's 87.49 billion. Earnings were 19.13 billion, an increase of 49.23%.